What long-term side effects can methotrexate cause?
Methotrexate can cause side effects that appear after months or years of use, particularly when doses are higher, kidney function is reduced, liver disease is present, or drug levels build up. Common longer-term concerns include:
Long-term liver effects. Methotrexate can cause liver inflammation and scarring (fibrosis/cirrhosis) in some people, especially with prolonged exposure and in those with additional risk factors such as heavy alcohol use or existing liver disease.
Blood and bone marrow effects. Over time, methotrexate can suppress blood cell production, leading to anemia (low red blood cells), leukopenia (low white blood cells), or thrombocytopenia (low platelets). This can increase fatigue and infections, or cause easy bruising/bleeding.
Lung toxicity (rare, but serious). Methotrexate can cause lung injury, sometimes called methotrexate pneumonitis. It is uncommon, but clinicians watch for symptoms such as a persistent dry cough or shortness of breath, because this can be hard to distinguish from infections or other lung conditions.
Kidney-related accumulation. Because methotrexate is cleared through the kidneys, reduced kidney function can increase exposure and the risk of side effects over time, including blood count and mucosal problems.
What symptoms should patients watch for over time?
People on long-term methotrexate are often advised to report symptoms promptly, especially:
- Persistent or worsening cough, shortness of breath, chest discomfort (possible lung involvement)
- Unusual bruising or bleeding, frequent infections, marked fatigue (possible blood count effects)
- Ongoing nausea, mouth sores, or worsening mouth ulcers (ongoing mucosal toxicity)
- Symptoms that could suggest liver problems, such as right upper abdominal discomfort, yellowing of the skin/eyes, or dark urine
If any of these occur, prescribers typically order labs and may pause methotrexate while evaluating the cause.
How do doctors reduce long-term risk?
Clinicians manage long-term risk with regular monitoring and dose adjustments, commonly including:
- Periodic blood tests to check liver function and blood counts
- Kidney function monitoring to ensure methotrexate is being cleared safely
- Avoiding alcohol or minimizing it, and checking for other liver risk factors
- Using folic acid (often prescribed alongside methotrexate) to reduce some side effects like mouth sores and certain blood count issues
Whether monitoring is needed more often depends on the person’s dose, underlying disease, age, and kidney function.
Do long-term side effects depend on dose or the condition being treated?
Yes. Risk generally rises with:
- Higher methotrexate doses and longer duration
- Reduced kidney function
- Pre-existing liver disease or significant alcohol intake
- Other medications that affect the liver or bone marrow
The underlying inflammatory disease (for example, rheumatoid arthritis or psoriasis) also influences baseline risk for infections and organ complications, which can complicate symptom interpretation.
What about infertility or cancer risk long term?
Methotrexate has a complicated long-term risk profile that depends heavily on the patient population and dosing. If you are asking specifically about infertility, pregnancy, or cancer risk, the most accurate guidance is individualized and tied to your dosing regimen and treatment goals. Your prescriber can review your personal risk factors and timing of therapy, including when it should be stopped before conception.
When should methotrexate be stopped or urgently evaluated?
Seek urgent medical evaluation if there are signs of serious adverse effects such as:
- Trouble breathing or rapidly worsening shortness of breath
- Severe mouth sores, inability to keep fluids down, or profound fatigue with signs of infection
- Significant bleeding or symptoms consistent with severe low blood counts
- Yellowing of the skin/eyes or dark urine suggesting liver injury
Because lung and blood complications can be serious, clinicians typically treat these symptoms as red flags even if they are uncommon.
Sources
- DrugSafety information on methotrexate (FDA label)
- DrugPatentWatch (methotrexate-related resources)
If you tell me your dose, how long you’ve been taking methotrexate, your diagnosis (RA, psoriasis, etc.), and whether you have kidney or liver issues, I can tailor which long-term side effects are most relevant to your situation.